Rishabh Chawla is currently a Principal at Gimv, where they have advanced from a Senior Associate since 2021. They serve as a Board Observer for both Kinaset Therapeutics and Complement Therapeutics and have held positions in various analytical and consulting roles across the life sciences sector. Rishabh's earlier experience includes an Equity Research Internship at Kempen & Co and an internship at Sir Ganga Ram Hospital, focusing on genetic typing. They earned a Ph.D. in Biochemistry and Molecular Biology from the University of Tübingen, following a Master's from the University of Glasgow and a Bachelor's from Vellore Institute of Technology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices